Article in American journal of physiology. Lung cellular and molecular physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Lyndsey E Shorey-KendrickDivision of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States.ORCID 0000-0001-8060-0097
B Adam CroslandDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, United States.
Matthias C SchabelAdvanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon, United States.ORCID 0000-0002-3183-7212
Ilhem MessaoudiDepartment of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, Kentucky, United States.
Minzhe GuoDivision of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States.ORCID 0000-0002-5502-9172
Matthew G DrakeDivision of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, United States.ORCID 0000-0001-5476-0361
Zhenying NieDivision of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, United States.ORCID 0000-0002-2521-5580
R Clayton EdenfieldDivision of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Sciences University, Beaverton, Oregon, United States.ORCID 0000-0003-3449-3555
Issac CincoDepartment of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, Kentucky, United States.
Michael H DaviesDivision of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States.
Jason A GrahamDivision of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Sciences University, Beaverton, Oregon, United States.
Olivia L HagenDivision of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Sciences University, Beaverton, Oregon, United States.ORCID 0009-0001-0369-5819
Owen J T McCartyDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, United States.ORCID 0000-0001-9481-0124
Cindy T McEvoyDivision of Neonatology, Department of Pediatrics, Oregon Health & Science University, Portland, Oregon, United States.ORCID 0000-0001-8501-8813
Eliot R SpindelDivision of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States.
Jamie O LoDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, United States.ORCID 0000-0002-1934-1935
Funding
Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
REPRODUCTIVE SCIENTIST TRAINING PROGRAMK12HD000849 · NICHD · WASHINGTON UNIVERSITY · PI Danny J Schust · 1988 to 2026
$33.2M
OHSU Women's Reproductive Health Research K12 ProgramK12HD085809 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Aaron B Caughey · 2015 to 2026
$4.0M
Impact of maternal marijuana use on epigenetic regulation of offspring neurodevelopmentDP1DA056493 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Jamie Lo · 2022 to 2026
$2.6M
Insulin increases nerve-mediated bronchoconstriction in obesity-related asthmaR01HL163087 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALLISON Deborah FRYER, Zhenying Nie · 2023 to 2026
$2.4M
Mechanisms of airway hyperresponsiveness in the offspring of obese mothersR01HL164474 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI MALOYAN, ALINA, NIE, ZHENYING · 2022 to 2025
$2.4M
Understanding the effects of moderate vs. heavy chronic maternal marijuana exposure in a non-human primate modelR03HD097116 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI LO, JAMIE · 2019 to 2020
$175k
Shared Instrumentation Grant application for EchoMRI whole body composition analyzerS10OD034444 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI NIE, ZHENYING · 2024 to 2024
$137k
March of Dimes Foundation (MDF) Basil O'ConnorNHLBI NIH HHS R01 HL163087NHLBI NIH HHS R01 HL164474NICHD NIH HHS K12 HD000849NICHD NIH HHS K12 HD085809NICHD NIH HHS R03 HD097116NIDA NIH HHS DP1 DA056493NIH HHS P51 OD011092NIH HHS S10 OD034444ODCDC CDC HHS P51 OD011092Silver Family Foundation
6 · The paper itself
Abstract
Prenatal cannabis use is rising, in part due to legalization and perceptions of safety. The impact of prenatal cannabis exposure on offspring development, especially respiratory health, remains largely unknown. The objective of this study was to determine whether in utero exposure to delta-9-tetrahydrocannabinol (THC), the main psychoactive component of cannabis, is deleterious to offspring lung development and function using a rhesus macaque model. Female rhesus macaques received a daily edible containing either THC (2.5 mg/7 kg/day, equivalent to a heavy medical cannabis dose) or placebo during gestation and postnatally. Serial in utero magnetic resonance imaging (MRI) was performed during pregnancy at approximately gestational days (G)110 and G150. At 6 mo of age, infants underwent pulmonary function testing, followed by tissue collection for molecular analysis (bulk RNAseq, whole genome bisulfite sequencing, and spatial RNAseq). THC-exposed infants displayed significantly reduced forced residual capacity, which correlated with nonsignificant decreases in total lung capacity, lung diffusion capacity and lower fetal lung perfusion, oxygen availability, and lung volume measured by MRI. Consistent with these decreases in volume indices, levels of pulmonary growth factors were decreased in bronchial alveolar lavage at 6 mo. Molecular analysis of infant lungs revealed altered epigenetic regulation of gene expression, including at genes involved in extracellular matrix organization and lung development, and activation of immune signaling. Our study suggests that exposure to prenatal edible THC alters epigenetic regulation of lung gene expression and may negatively affect offspring lung development and function. Data from this study will help guide healthcare provider counseling on cannabis use in pregnancy.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.